117 related articles for article (PubMed ID: 3958619)
1. Desorption chemical ionization mass spectrometry of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholines and analogues.
Thomas MJ; Samuel M; Wykle RL; Surles JR; Piantadosi C
J Lipid Res; 1986 Feb; 27(2):172-6. PubMed ID: 3958619
[TBL] [Abstract][Full Text] [Related]
2. Observations on the critical micellar concentration of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine and a series of its homologs and analogs.
Kramp W; Pieroni G; Pinckard RN; Hanahan DJ
Chem Phys Lipids; 1984 May; 35(1):49-62. PubMed ID: 6744496
[TBL] [Abstract][Full Text] [Related]
3. Relative amounts of 1-O-alkyl- and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in stimulated endothelial cells.
Whatley RE; Clay KL; Chilton FH; Triggiani M; Zimmerman GA; McIntyre TM; Prescott SM
Prostaglandins; 1992 Jan; 43(1):21-9. PubMed ID: 1546171
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of optically active 1-acyl-2-O-alkyl-sn-glycero-3-phosphocholine via 1-O-benzyl-sn-glycerol 3-arenesulfonate.
Ali S; Bittman R
Biochem Cell Biol; 1990 Jan; 68(1):360-5. PubMed ID: 2350497
[TBL] [Abstract][Full Text] [Related]
5. Acetylcholine-like effects of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine ('platelet-activating factor') and its analogues in exocrine secretory glands.
Söling HD; Eibl H; Fest W
Eur J Biochem; 1984 Oct; 144(1):65-72. PubMed ID: 6207023
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of trideuterated O-alkyl platelet activating factor and lyso derivatives.
Prakash C; Saleh S; Taber DF; Blair IA
Lipids; 1989 Sep; 24(9):786-92. PubMed ID: 2586235
[TBL] [Abstract][Full Text] [Related]
7. Ether phospholipids as inhibitors of the arachidonoyl-CoA: 1-acyl-sn-glycero-3-phosphocholine acyltransferase in macrophages.
Herrmann DB; Ferber E; Munder PG
Biochim Biophys Acta; 1986 Mar; 876(1):28-35. PubMed ID: 3947667
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 1-O-alkyl-, 1-O-alk-1'-enyl-, and 1-O-acyl-2-acetyl-sn-glycero-3-phosphoethanolamines and -3-phosphocholines as agonists of the platelet-activating factor family.
O'Flaherty JT; Tessner T; Greene D; Redman JR; Wykle RL
Biochim Biophys Acta; 1994 Jan; 1210(2):209-16. PubMed ID: 8280772
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cells.
Blank ML; Spector AA; Kaduce TL; Lee TC; Snyder F
Biochim Biophys Acta; 1986 May; 876(3):373-8. PubMed ID: 3707974
[TBL] [Abstract][Full Text] [Related]
10. Facile synthesis of platelet-activating factor and racemic analogues containing unsaturation in the sn-1-alkyl chain.
Surles JR; Wykle RL; O'Flaherty JT; Salzer WL; Thomas MJ; Snyder F; Piantadosi C
J Med Chem; 1985 Jan; 28(1):73-8. PubMed ID: 4038418
[TBL] [Abstract][Full Text] [Related]
11. Measurement of sub-picogram quantities of platelet activating factor (AGEPC) by gas chromatography/negative ion chemical ionization mass spectrometry.
Ramesha CS; Pickett WC
Biomed Environ Mass Spectrom; 1986 Mar; 13(3):107-11. PubMed ID: 2938649
[TBL] [Abstract][Full Text] [Related]
12. The enantiomer and the positional isomer of platelet-activating factor.
Tence M; Coëffier E; Polonsky J; Benveniste J
Biochim Biophys Acta; 1983 Feb; 755(3):526-30. PubMed ID: 6824744
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to synthetic platelet-activating factor (1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine) analogues with substituents at the sn-2 position.
Karasawa K; Satoh N; Masuda M; Setaka M; Hashimoto K; Ishibashi K; Nojima S
J Biochem; 1991 Nov; 110(5):683-7. PubMed ID: 1723729
[TBL] [Abstract][Full Text] [Related]
14. A Penicillium sp. F33 metabolite and its synthetic derivatives inhibit acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and carrageenan-induced paw edema in mice.
Yamazaki Y; Yasuda K; Matsuyama T; Ishihara T; Higa R; Sawairi T; Yamaguchi M; Egi M; Akai S; Miyase T; Ikari A; Miwa M; Sugatani J
Biochem Pharmacol; 2013 Sep; 86(5):632-44. PubMed ID: 23817078
[TBL] [Abstract][Full Text] [Related]
15. Biosynthesis of platelet activating factor and 1-O-acyl analogues by endothelial cells.
Clay KL; Johnson C; Worthen GS
Biochim Biophys Acta; 1991 Aug; 1094(1):43-50. PubMed ID: 1909182
[TBL] [Abstract][Full Text] [Related]
16. Conversion of 1-alkyl-2-acetyl-sn-glycerols to platelet activating factor and related phospholipids by rabbit platelets.
Blank ML; Lee TC; Cress EA; Malone B; Fitzgerald V; Snyder F
Biochem Biophys Res Commun; 1984 Oct; 124(1):156-63. PubMed ID: 6497876
[TBL] [Abstract][Full Text] [Related]
17. Production and characterization of specific antibodies against 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a potent hypotensive and platelet-activating ether-linked phospholipid).
Nishihira J; Ishibashi T; Imai Y
J Biochem; 1984 May; 95(5):1247-51. PubMed ID: 6430883
[TBL] [Abstract][Full Text] [Related]
18. Semi-synthetic preparation of 1-O-[1'-14C]hexadecyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) using plant cell cultures.
Weber N; Mangold HK
J Lipid Res; 1985 Apr; 26(4):495-500. PubMed ID: 3891896
[TBL] [Abstract][Full Text] [Related]
19. Ether lipid content and fatty acid distribution in rabbit polymorphonuclear neutrophil phospholipids.
Mueller HW; O'Flaherty JT; Wykle RL
Lipids; 1982 Feb; 17(2):72-7. PubMed ID: 7087685
[TBL] [Abstract][Full Text] [Related]
20. Chemo-enzymatic synthesis of rac 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine and its analogues.
Vijeeta T; Balakrishna M; Lakshmi Karuna MS; Surya Koppeswara Rao BV; Narayana Prasad RB
J Oleo Sci; 2014; 63(9):933-8. PubMed ID: 25174676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
